The results, while unpublished, are the latest in a string of hopeful signs for weight loss drugs to treat a variety of ...

The program spent $5.7 billion on drugs such as Ozempic and Mounjaro in 2022, according to the Kaiser Family Foundation.

Weight-loss drug developer Metsera has raised $290 million in funding, led by biotech investor ARCH Venture Partners as well as participation from firms such as SoftBank and Mubadala Capital, the ...

William Blair analysts say that new data supporting GLP-1s for sleep apnea shouldn't displace companies like ResMed in the ...

We’ve heard a lot about the impacts of Ozempic recently, from rapid weight loss and lowered blood pressure, to persistent vomiting and “Ozempic face”. Now we’re seeing a rise in stories about “Ozempic ...

A late-stage trial of Cerevel Therapeutic’s Parkinson’s disease drug showed a significant reduction in the time patients ...

Some water weight is normal, says Jessica Cording, M.S., R.D., author of The Little Book of Game-Changers: 50 Healthy Habits ...

Results from the Phase 3 SELECT-GCA study showed 46 percent of patients with giant cell arteritis (GCA) who were treated with upadacitinib (RINVOQ®; 15 mg) with a 26-week steroid taper regimen achieve ...

The clinical-stage biotech emerged from stealth on Thursday with several oral and injectable candidates, including a GLP-1 ...

The metabolic conditions of type 2 diabetes and polycystic ovary syndrome (PCOS) are both linked to obesity and fertility ...